Goepper Burkhardt’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $663K | Sell |
3,572
-28
| -0.8% | -$5.2K | 0.24% | 49 |
|
|
2025
Q1 | $754K | Buy |
3,600
+46
| +1% | +$9.64K | 0.3% | 40 |
|
|
2024
Q4 | $632K | Sell |
3,554
-101
| -3% | -$17.9K | 0.26% | 43 |
|
|
2024
Q3 | $722K | Hold |
3,655
| – | – | 0.3% | 40 |
|
|
2024
Q2 | $627K | Buy |
3,655
+3
| +0.1% | +$514 | 0.28% | 41 |
|
|
2024
Q1 | $587K | Buy |
3,652
+206
| +6% | +$33.1K | 0.27% | 44 |
|
|
2023
Q4 | $600K | Buy |
3,446
+36
| +1% | +$6.27K | 0.3% | 39 |
|
|
2023
Q3 | $508K | Buy |
3,410
+2
| +0.1% | +$298 | 0.31% | 33 |
|
|
2023
Q2 | $459K | Sell |
3,408
-99
| -3% | -$13.3K | 0.28% | 37 |
|
|
2023
Q1 | $559K | Buy |
3,507
+1
| +0% | +$159 | 0.37% | 28 |
|
|
2022
Q4 | $567K | Buy |
3,506
+67
| +2% | +$10.8K | 0.4% | 28 |
|
|
2022
Q3 | $462K | Sell |
3,439
-131
| -4% | -$17.6K | 0.34% | 30 |
|
|
2022
Q2 | $547K | Buy |
3,570
+433
| +14% | +$66.3K | 0.39% | 30 |
|
|
2022
Q1 | $509K | Hold |
3,137
| – | – | 0.31% | 35 |
|
|
2021
Q4 | $425K | Buy |
3,137
+1
| +0% | +$135 | 0.25% | 41 |
|
|
2021
Q3 | $338K | Buy |
3,136
+1
| +0% | +$108 | 0.22% | 46 |
|
|
2021
Q2 | $353K | Buy |
3,135
+85
| +3% | +$9.57K | 0.22% | 46 |
|
|
2021
Q1 | $330K | Buy |
3,050
+192
| +7% | +$20.8K | 0.22% | 45 |
|
|
2020
Q4 | $306K | Buy |
+2,858
| New | +$306K | 0.22% | 46 |
|